Corporate News
- Alle
- Social Media Feeds
- Unternehmensnachrichten
- Veranstaltungen & Ausstellungen
April 28, 2022
OUR STAFF
Januar 15, 2022
FarmaMondo and Accendatech USA Inc. partnered to initiate a Managed Access Program for the compassionate supply of ACT-001 for patients in Hong Kong
September 10, 2021
Mirum pharmaceuticals and FarmaMondo Group enter into an exclusive commercialization agreement for Russia and CIS region
Juli 26, 2021
Ideogen AG and FarmaMondo enter into a managed access program agreement to allow Fotolyn, Beleodaq and Marqibo distribution in Russia, CIS market and Baltics
Dezember 27, 2020
Sarepta Therapeutics and FarmaMondo announce an agreement to exclusively manage access of eteplirsen and golodirsen in Russia
November 10, 2020
Dompe‘ farmaceutici and the FarmaMondo Group: exclusive agreement to distribute oxervate™ in Russia and other CIS countries
Juni 1, 2020
FarmaMondo to exclusively manage access to Metreleptin (Myalept®) by Amryt Pharma for patients with lipodystrophy in CIS (excluding Russia)
April 14, 2020
EUSA and FarmaMondo Group establishes an Emergency Managed Access Program to allow Healthcare Providers to access Siltuximab (Sylvant©) for off label treatment of acute patients of COVID-19
Oktober 2, 2019
FarmaMondo to exclusively Manage Access to Lomitapide (Lojuxta®) for the Swiss and CIS markets
Juni 1, 2019
FarmaMondo to exclusively manage access of Qarziba® (Dinutuximab Beta) by EUSA Pharma for patients with High Risk Neuroblastoma in LATAM and APAC regions
August 20, 2018
FarmaMondo to manage access to Asparaginase (Spectrila® by Medac Pharma) for patients with acute lymphoblastic leukemia in Russia and CIS region
März 15, 2018
FarmaMondo appointed by Amomed Pharma to exclusively Manage Access for Argipressin (Empressin®) for Russia and CIS region
Januar 1, 2018
FarmaMondo establishes presence in south EU markets to provide direct to hospital service around supply of unlicensed medicines
November 1, 2017
FarmaMondo establishes presence in Mexico to provide direct to hospital service around supply of unlicensed medicines
Oktober 17, 2017
FarmaMondo to manage access to Dinutuximab beta EUSA for patients with Neuroblastoma
Oktober 17, 2017
FarmaMondo to manage access to Qarziba® (Dinutuximab Beta) by EUSA Pharma) for patients with High Risk Neuroblastoma in Russia and CIS region
August 15, 2013